Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer

Antigen-presenting genes and genomic copy number variations in the Tasmanian devil MHC

(2012) Yuanyuan Cheng et al.   BMC GENOMICS

Genome Sequencing and Analysis of the Tasmanian Devil and Its Transmissible Cancer

(2012) Elizabeth P. Murchison et al.   CELL

New Insights into the Role of MHC Diversity in Devil Facial Tumour Disease

(2012) Amanda Lane et al.   PLoS One

Genomic Restructuring in the Tasmanian Devil Facial Tumour: Chromosome Painting and Gene Mapping Provide Clues to Evolution of a Transmissible Tumour

(2012) Janine E. Deakin et al.   PLoS Genetics

Allorecognition in the Tasmanian Devil (Sarcophilus harrisii), an Endangered Marsupial Species with Limited Genetic Diversity

(2011) Alexandre Kreiss et al.   PLoS One

The dominantly expressed class I molecule of the chicken MHC is explained by coevolution with the polymorphic peptide transporter (TAP) genes

(2011) B. A. Walker et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Tasmanian Devil Transcriptome Reveals Schwann Cell Origins of a Clonally Transmissible Cancer

(2010) E. P. Murchison et al.   SCIENCE

ORIGINS AND EVOLUTION OF A TRANSMISSIBLE CANCER

(2009) Clare A. Rebbeck et al.   EVOLUTION

Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation

(2009) Gerd Meyer zu Hörste et al.   NEUROBIOLOGY OF DISEASE

Interactions of host IL-6 and IFN-γ and cancer-derived TGF-β1 on MHC molecule expression during tumor spontaneous regression

(2008) Ya-Wen Hsiao et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY